Contract 36E79725D0014
Accord Biopharma, Inc. · Department Of Veterans Affairs · November 21, 2025
Accord Biopharma, Inc. was awarded a federal contract by Department Of Veterans Affairs on November 21, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 17, 2026. If all options are exercised, the contract could reach $27.63 million.
Contract details
- PIID
- 36E79725D0014
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- November 21, 2025
- Latest action
- March 17, 2026
Description
THIS MODIFICATION IS ISSUED TO INCORPORATE A NOVATION AGREEMENT INTO NATIONAL CONTRACT 36E79725D0014.
Modification timeline
-
March 17, 2026Mod P00004 · Novation Agreement$0
-
March 10, 2026Mod P00003 · Exercise An OptionTHIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 1 ON NC 36E79725D0014 WITH A PERIOD OF PERFORMANCE OF 4/11/2026 TO 4/10/2027.$0
-
February 5, 2026Mod P00002 · Supplemental Agreement For Work Within ScopeTHIS MODIFICATION IS ISSUED TO INCORPORATE AN NDC ADDITION INTO NC 36E79725D0014.$0
-
November 21, 2025Mod P00001 · Other Administrative ActionTHIS MODIFICATION IS ISSUED TO INCORPORATE 2026 FEDERAL CEILING PRICES FOR NC 36E79725D0014.$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79725D0014?
Contract 36E79725D0014 is a federal contract awarded to Accord Biopharma, Inc. by Department Of Veterans Affairs on November 21, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 36E79725D0014?
Accord Biopharma, Inc. won contract 36E79725D0014 from Department Of Veterans Affairs.
How much is contract 36E79725D0014 worth?
Contract 36E79725D0014 has obligated $0 to date but carries a potential ceiling of $27.63 million if fully funded and all options are exercised.